Skip to content

MAIA - MAIA Biotechnology, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

MAIA Biotechnology Inc.

MAIA · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MAIAMAIA Biotechnology Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.19
52-wk low: $0.87
Prev close: $1.97
Mkt cap: $83.9M
Beta: 0.25
P/B: 4.1x

Smart money

7 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

7 holders

Combined position$1.6M

JS
Jim Simons
Q2 2026 13F
$599K
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 18.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $84M

Valuation

P/B4.09

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MAIA
Exchange: AMEX
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $83.94M
Beta: 0.25

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-218.7%

$73K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$36K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for MAIA

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.13-18.2%

-$0.11 expected

Next report

What the street expects next

-218.7%

ROA-92.1%

Growth

Beta0.25